Practical Guide to Hereditary Breast and Ovarian Cancer (Record no. 29533)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 04345nam a22002777a 4500 |
001 - CONTROL NUMBER | |
control field | 20241101124951.0 |
003 - CONTROL NUMBER IDENTIFIER | |
control field | OCoLC |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20241101125430.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 241101b |||||||| |||| 00| 0 eng d |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
International Standard Book Number | 978-981-99-5230-4 |
International Standard Book Number | 978-981-99-5231-1 (eBook) |
040 ## - CATALOGING SOURCE | |
Transcribing agency | ddc |
041 ## - LANGUAGE CODE | |
Language code of text/sound track or separate title | English |
100 ## - MAIN ENTRY--PERSONAL NAME | |
Fuller form of name | Daisuke Aoki |
222 ## - KEY TITLE | |
Key title | assay associated ATF1 autologous BARD1 BRCA BRCA mutation BRCA1 and BRCA2 BRCA1/2 genetic testing BRCA1/2 mutations BRCA1/2 pathogenic variant BRCA2 mutation carriers breast and ovarian breast cancer breast cancer patients breast implant breast or ovarian breast reconstruction Cancer Res cancer risk cancer types cells centriole centrosome CGP Clin Oncol clinical ClinVar covered covered CRRM diagnosis DNA evaluate fallopian tube family history Fig frequency functional genetic counseling genomic germline findings germline genetic testing germline pathogenic variants germline variants Guide to Hereditary Gynecol HBOC health insurance Hereditary Breast hereditary cancer HGSC high-grade serous homologous recombination HR activity HR-deficient HRD identified Japan Japanese JOHBOC lesions mastectomy Momozawa Nat OLA1 olaparib Oncology oophorectomy ovarian cancer ovarian cancer HBOC ovarian cancer patients p53 signature PALB2 pancreatic cancer PARP inhibitors PGPVs prostate cancer protein recommended registry repair reported risk-reducing salpingo-oophorectomy salpingo-oophorectomy sequencing serous tubal intraepithelial somatic STIC surveillance target tion TNBC VUS women |
245 ## - TITLE STATEMENT | |
Title | Practical Guide to Hereditary Breast and Ovarian Cancer |
Remainder of title | Annual Meeting of the Japanese Organization of Hereditary Breast and Ovarian Cancer 2021. |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Place of publication, distribution, etc. | Akasaka Sanno Medical Center International University of Health and Welfare Graduate School Minato-ku, Tokyo, Japan | |
Name of publisher, distributor, etc. | Springer Nature Singapore Pte Ltd | |
Date of publication, distribution, etc. | 2023 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 147 Pages |
Extent | Includes References |
520 ## - SUMMARY, ETC. | |
Summary, etc. | This book shares cutting-edge evidence on Hereditary Breast and Ovarian Cancer (HBOC) treatment, delivering facts on breast cancer, gynecologic oncology, and basic research to contribute to clinicians' practices. Each chapter presents the latest clinical techniques, basic experimental results, and the best-chosen research findings. The book is based on the works presented at the Japanese Organization of Hereditary Brest and Ovarian Cancer (JOHBOC) and a special chapter delivers a study based on the extensive data from the Japanese HBOC patients registered in the society's database, presenting novel evidence for further advancement in the field.<br/><br/>The practice for HBOC has been rapidly increasing due to the clinical development of poly(ADP-ribose) polymerase inhibitors and the spread of companion diagnostics. In addition, the insurance coverage of a part of HBOC treatment raised social awareness in Japan, and the book illustrates not only clinical efforts but also issues related to the social system and the efforts of the association of related organizations.<br/><br/>Hereditary Breast and Ovarian Cancer – Annual meeting of JOHBOC will be of interest to breast surgeons, obstetricians and gynecologists, pancreatic cancer surgeons, and urologists engaged in HBOC treatment through the implementation of companion diagnostics for PARP inhibitors administration. Also, physicians occupied in genetic medicine who perform genetic testing and medical staff practicing HBOC will find this book insightful. It is also for HBOC patients and their families, medical administrators in the social system of HBOC practice. Editors and authors hope to contribute to the equalization and widespread of HBOC practice and serve as a foundation for future advances in the disease's treatment and medical practice. |
600 ## - SUBJECT ADDED ENTRY--PERSONAL NAME | |
General subdivision | Biology—Research, Cancer—Genetic aspects, Endoscopic surgery, Medical / Clinical Medicine, Medical / General, Medical / Oncology / General, Medical / Research, Medical / Surgery / General, Medicine—Research, Oncology, Science / Life Sciences / Genetics & Genomics, Surgery, Breast -- Congresses -- Cancer -- Genetic aspects, Ovaries -- Congresses -- Cancer -- Genetic aspects |
700 ## - ADDED ENTRY--PERSONAL NAME | |
Fuller form of name | Seigo Nakamura |
Fuller form of name | Yoshio Miki Editors |
856 ## - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1007/978-981-99-5231-1 ">https://doi.org/10.1007/978-981-99-5231-1 </a> |
942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
Source of classification or shelving scheme | ddc |
Koha item type | E-BOOKS |
Suppress in OPAC |
Withdrawn status | Lost status | Source of classification or shelving scheme | Damaged status | Not for loan | Home library | Current library | Date acquired | Coded location qualifier | Total checkouts | Barcode | Date last seen | Copy number | Uniform resource identifier | Price effective from | Koha item type |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO | MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO | 11/01/2024 | S/OFFICE | 20241101124951.0 | 11/01/2024 | 20241101124951.0 | https://doi.org/10.1007/978-981-99-5231-1 | 11/01/2024 | E-BOOKS |